Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

España, Pedro Pablo; Capelastegui, Alberto; Quintana, José M.; Bilbao, Amaia; Díez, Rosa; Pascual, Sílvia; Esteban, Cristóbal; Zalacaín, Rafael; Menéndez, Rosário; Torres, Antoni

doi:10.1016/j.jinf.2009.11.013

Cited by 35 publications

(20 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fifty-five patients had multilobar/bilateral lung affectation in X-rays in the study. This is far higher than the incidence reported in the studies of España (6)(7)(8). One reason was that 124 patients (24.6%) were aspiration pneumonia, and 86 patients of them (69.4%) had multilobar/bilateral lung affectation in this study.…”

Section: Discussioncontrasting

confidence: 53%

“…Patients who are identified as not severe by España rule are unlikely to die or require intensive care. España et al demonstrated its usefulness for identifying low-risk patients (8).…”

Section: Discussionmentioning

confidence: 99%

“…In a recent article, España and colleagues have reported a new clinical prediction rule for severe community acquired pneumonia (SCAP) (6)(7)(8). Using prospective and retrospective data from five Spanish hospitals, España and colleagues identified eight clinically available variables that can help identify patients with or at risk for hospital mortality, need for mechanical ventilation, and septic shock.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

et al. 2011

View full text Add to dashboard Cite

Objective Several scoring systems have been derived to identify patients with severe community-acquired pneumonia (CAP). Recently, España et al (Am J Respir Crit Care Med 174:1249-1256, 2006) developed a clinical prediction rule that predicts hospital mortality, the need for mechanical ventilation, and risk for septic shock. We assessed the performance of this rule and compared it with other published scoring systems. Methods A prospective study was conducted of patients with CAP who were hospitalized at our hospital from April 2007 till May 2009. Clinical and laboratory features at presentation were recorded and used in order to calculate España rule, the pneumonia severity index (PSI), CURB-65, A-DROP, the 2007 Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) prediction rule and SMART-COP. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were compared for adverse outcomes. We also assessed the association of the España rule criteria and adverse outcomes. Results A total of 505 patients were enrolled in the study. The overall in-hospital mortality rate was 6.5%, and 6.3% of patients were admitted to the intensive care unit (ICU). Sixty-two (12.3%) patients were defined as having severe CAP (in-hospital death or need for mechanical ventilation or septic shock). España rule achieved highest sensitivity and NPV in predicting severe CAP. When ICU admission was the outcome measure, the IDSA/ATS rule and SMART-COP were regarded to be good predictors. Conclusion España rule performed well in identifying patients with severe CAP. As a result, each of the severity scores has advantages and limitations for predicting adverse outcomes.

show abstract

Section: Discussioncontrasting

confidence: 53%

“…Patients who are identified as not severe by España rule are unlikely to die or require intensive care. España et al demonstrated its usefulness for identifying low-risk patients (8).…”

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

et al. 2011

View full text Add to dashboard Cite

show abstract

“…5 It has been validated for the prediction of mortality in patients at low risk of mortality. 6 Some of these instruments have been used to address the challenge of identifying patients with CAP who can be safely treated as outpatients rather than requiring hospitalization, 7 and yet there are limited and controversial data regarding whether patients at low risk of dying based on severity criteria require admission to hospital. 8 The clinical staff should be able to recognize patients in need of any type of intensified monitoring and treatment, that is to say, patients who present with or are at risk of developing complications.…”

Section: Introductionmentioning

confidence: 99%

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia

España

Capelastegui

Mar

et al. 2015

Journal of Infection

Self Cite

View full text Add to dashboard Cite

“…However, the SMART-COP system was developed in a study to investigate the need for IRVS (13). There are conflicting results between some studies on the PSI and CURB-65 systems regarding which method is superior for predicting mortality (15,(23)(24)(25)(26). Many authors reported a continued reliance on clinical judgment (27).…”

Section: Discussionmentioning

confidence: 99%

Comparison of Severity Scoring Systems in Community-Acquired Pneumonia

Alıcı¹,

Çapan²,

Ertürk³

et al. 2015

Eurasian J Pulmonol

View full text Add to dashboard Cite

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

Cited by 35 publications

References 32 publications

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia

Comparison of Severity Scoring Systems in Community-Acquired Pneumonia

Contact Info

Product

Resources

About